Case Report
Published on 09 Oct 2025
Case Report: Fluzoparib combined Exemestane in gBRCA2-mutated HR+/HER2− advanced breast cancer
in Pharmacology of Anti-Cancer Drugs
- 1,358 views
- 1 citation
Case Report
Published on 09 Oct 2025
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 22 Mar 2022
in Polymer Chemistry
Clinical Case Study
Published on 19 Apr 2013
in Pharmacology of Anti-Cancer Drugs
Case Report
Published on 30 Nov 2022
in Breast Cancer
Original Research
Published on 12 Mar 2025
in Breast Cancer
Original Research
Published on 14 May 2025
in Pharmacoepidemiology
Case Report
Published on 21 Aug 2025
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Original Research
Published on 17 Jan 2022
in Breast Cancer
Systematic Review
Published on 30 May 2022
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 10 Feb 2022
in Breast Cancer
Case Report
Published on 23 Dec 2022
in Breast Cancer
Original Research
Published on 23 Feb 2024
in Drugs Outcomes Research and Policies
Case Report
Published on 09 Jan 2023
in Breast Cancer